康华生物：川发精选3号减持40万股

Group 1 - The core point of the article is that Kanghua Biological announced a share reduction by a major shareholder, which may impact investor sentiment and stock performance [1][2] Group 2 - Kanghua Biological reported a revenue of 840 million yuan and a net profit attributable to shareholders of 189 million yuan for the first three quarters of 2025 [2] - The shareholder, Chuanfa Selected No. 3, reduced its holdings by 400,000 shares, accounting for 0.3056% of the company's total share capital [1][2]